NCT04203173

Brief Summary

The objective of this protocol is to answer the questions: 1) Are financial incentives layered upon nurse education and home telemonitoring superior to nurse education and home telemonitoring alone in improving metabolic control long term? 2) Are the effects of financial incentives on metabolic control sustained once the incentives are withdrawn? and 3) Are financial incentives efficacious within and consistent across racial/ethnic groups? This study provides a unique opportunity to address these gaps in the literature. Investigators propose a randomized controlled trial to test the efficacy of a Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) intervention comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives; compared to an active control group (nurse education and home telemonitoring alone). The study also will evaluate whether intervention effects are sustained 6 months after the financial incentives are withdrawn (i.e. 18 months post randomization); and whether the intervention is differentially efficacious across racial/ethnic groups.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
450

participants targeted

Target at P75+ for not_applicable type-2-diabetes

Timeline
Completed

Started Dec 2019

Longer than P75 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

December 1, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 18, 2019

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

5.6 years

First QC Date

November 26, 2019

Last Update Submit

August 4, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Glycemic control (HbA1c)

    Blood specimens (10cc of blood) will be obtained by trained phlebotomists or nurse for HbA1c.

    Change from baseline HbA1c at 12 months post intervention follow-ups

  • Resource Utilization and Cost

    Previously validated questions on resource utilization will be administered. The questionnaires capture information on hospitalizations, physician/professional visits, and medications.

    Change from baseline resource utilization and cost at at 12 months post-intervention follow-ups

Secondary Outcomes (5)

  • LDL-Cholesterol

    Change from baseline cholesterol at at 12 months post intervention follow-ups

  • Quality of Life as measured by SF-12

    Change from baseline quality of life measure at at 12 months post intervention follow-ups

  • Systolic and Diastolic Blood Pressure

    Change from baseline blood pressure at at 12 months post intervention follow-ups

  • Self-Care Behavior

    Change from baseline self-care at at 12 months post intervention follow-ups

  • Self-Care Behavior Brooks Medication Adherence Scale (BMAS)

    Change from baseline self-care at at 12 months post intervention follow-ups

Study Arms (2)

FINANCE-DM Intervention

EXPERIMENTAL

The FINANCE-DM intervention is comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives.

Behavioral: FINANCE-DM

TIDES Intervention

ACTIVE COMPARATOR

Patients randomized to the active comparator group will be assigned the FORA 2-in-1 Telehealth System. A nurse educator will review the glucose and BP readings and use them to tailor and reinforce behavior change.

Behavioral: Active Comparator

Interventions

FINANCE-DMBEHAVIORAL

The FINANCE-DM intervention is comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives. Patients randomized to FINANCE-DM will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. BG and BP will be measured daily and results will be uploaded to a secure server. A nurse educator will review the glucose and BP readings and use them to tailor and reinforce behavior change during weekly telephone-delivered diabetes education and skills training session. Participants will also receive financial rewards for: 1) uploading glucose measurements; 2) participating in telephone delivered educational sessions; and 3) absolute percentage drops in HbA1c from baseline at each 3-month follow-up intervals.

FINANCE-DM Intervention

Patients randomized to the active comparator group will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. BG and BP will be measured daily and results will be uploaded to a secure server. A nurse educator will review the glucose and BP readings and use them to tailor and reinforce behavior change during weekly telephone-delivered diabetes education and skills training session.

TIDES Intervention

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>=21 years;
  • Clinical diagnosis of T2DM and HbA1c \>=8% at the screening visit;
  • Self-identified as White, AA or HA;
  • Subject must be willing to use the FORA monitoring system for 12 months;
  • Subjects must have access to a landline, Ethernet or cellphone for FORA data uploads for the study period; and 6) Ability to communicate in English.

You may not qualify if:

  • Mental confusion on interview suggesting significant dementia;
  • Participation in other diabetes clinical trials;
  • Alcohol or drug abuse/dependency;
  • Active psychosis or acute mental disorder; and
  • Life expectancy \<18 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

State University of New York at Buffalo

Buffalo, New York, 14203, United States

Location

Related Publications (1)

  • Egede LE, Walker R, Williams JS, Knapp R, Dismuke CE, Davidson T, Campbell JA. Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol. BMJ Open. 2020 Dec 22;10(12):e043760. doi: 10.1136/bmjopen-2020-043760.

    PMID: 33371048BACKGROUND

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Leonard E Egede, MD, MS

    State University of New York at Buffalo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor & Chair, Department of Medicine

Study Record Dates

First Submitted

November 26, 2019

First Posted

December 18, 2019

Study Start

December 1, 2019

Primary Completion

June 30, 2025

Study Completion

March 31, 2026

Last Updated

August 6, 2025

Record last verified: 2025-08

Locations